Pharsight

Drugs that contain Esomeprazole Magnesium

1. Esomeprazole Magnesium patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10076494 DEXCEL Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(12 years from now)

US10835488 DEXCEL Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(12 years from now)

Market Authorisation Date: 20 October, 2020

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage

ESOMEPRAZOLE MAGNESIUM family patents

Family Patents

2. Nexium patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5877192 ASTRAZENECA Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
May, 2014

(10 years ago)

US6875872 ASTRAZENECA Compounds
May, 2014

(10 years ago)

US5690960 ASTRAZENECA Pharmaceutical formulation of omeprazole
Nov, 2014

(9 years ago)

US6875872

(Pediatric)

ASTRAZENECA Compounds
Nov, 2014

(9 years ago)

US5877192

(Pediatric)

ASTRAZENECA Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
Nov, 2014

(9 years ago)

US5714504 ASTRAZENECA Compositions
Feb, 2015

(9 years ago)

US5690960

(Pediatric)

ASTRAZENECA Pharmaceutical formulation of omeprazole
May, 2015

(9 years ago)

US5714504

(Pediatric)

ASTRAZENECA Compositions
Aug, 2015

(8 years ago)

US5900424 ASTRAZENECA Omeprazole magnesium salt form
May, 2016

(8 years ago)

US5900424

(Pediatric)

ASTRAZENECA Omeprazole magnesium salt form
Nov, 2016

(7 years ago)

US8466175 ASTRAZENECA Form of S-omeprazole
May, 2018

(6 years ago)

US7411070 ASTRAZENECA Form of S-omeprazole
May, 2018

(6 years ago)

US6369085 ASTRAZENECA Form of S-omeprazole
May, 2018

(6 years ago)

US6166213 ASTRAZENECA Omeprazole process and compositions thereof
Oct, 2018

(5 years ago)

US6147103 ASTRAZENECA Omeprazole process and compositions thereof
Oct, 2018

(5 years ago)

US6191148 ASTRAZENECA Omerazole process and compositions thereof
Oct, 2018

(5 years ago)

US6369085

(Pediatric)

ASTRAZENECA Form of S-omeprazole
Nov, 2018

(5 years ago)

US7411070

(Pediatric)

ASTRAZENECA Form of S-omeprazole
Nov, 2018

(5 years ago)

US8466175

(Pediatric)

ASTRAZENECA Form of S-omeprazole
Nov, 2018

(5 years ago)

US6147103

(Pediatric)

ASTRAZENECA Omeprazole process and compositions thereof
Apr, 2019

(5 years ago)

US6191148

(Pediatric)

ASTRAZENECA Omerazole process and compositions thereof
Apr, 2019

(5 years ago)

US6166213

(Pediatric)

ASTRAZENECA Omeprazole process and compositions thereof
Apr, 2019

(5 years ago)

US6428810 ASTRAZENECA Pharmaceutical formulation comprising omeprazole
Nov, 2019

(4 years ago)

US6428810

(Pediatric)

ASTRAZENECA Pharmaceutical formulation comprising omeprazole
May, 2020

(4 years ago)

Drug Exclusivity Drug Exclusivity Expiration
M(M-86) Jun 18, 2012
Pediatric Exclusivity(PED) Dec 18, 2012

Market Authorisation Date: 15 December, 2011

Treatment: Pathological hypersecretory conditions; Treatment of gastroesophageal reflux disease (gerd), risk-reduction of nsaid-associated gastric ulcer, h. pylori eradication to reduce the risk of duodenal ulce...

Dosage: FOR SUSPENSION, DELAYED RELEASE;ORAL; CAPSULE, DELAYED REL PELLETS;ORAL

How can I launch a generic of NEXIUM before it's drug patent expiration?
More Information on Dosage

NEXIUM family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Nexium 24hr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6875872 ASTRAZENECA LP Compounds
May, 2014

(10 years ago)

US5900424 ASTRAZENECA LP Omeprazole magnesium salt form
May, 2016

(8 years ago)

US7411070 ASTRAZENECA LP Form of S-omeprazole
May, 2018

(6 years ago)

US6369085 ASTRAZENECA LP Form of S-omeprazole
May, 2018

(6 years ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5877192 ASTRAZENECA LP Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
May, 2014

(10 years ago)

US5690960 ASTRAZENECA LP Pharmaceutical formulation of omeprazole
Nov, 2014

(9 years ago)

US5877192

(Pediatric)

ASTRAZENECA LP Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
Nov, 2014

(9 years ago)

US6875872

(Pediatric)

ASTRAZENECA LP Compounds
Nov, 2014

(9 years ago)

US5714504 ASTRAZENECA LP Compositions
Feb, 2015

(9 years ago)

US5690960

(Pediatric)

ASTRAZENECA LP Pharmaceutical formulation of omeprazole
May, 2015

(9 years ago)

US5714504

(Pediatric)

ASTRAZENECA LP Compositions
Aug, 2015

(8 years ago)

US5900424

(Pediatric)

ASTRAZENECA LP Omeprazole magnesium salt form
Nov, 2016

(7 years ago)

US7411070

(Pediatric)

ASTRAZENECA LP Form of S-omeprazole
Nov, 2018

(5 years ago)

US6369085

(Pediatric)

ASTRAZENECA LP Form of S-omeprazole
Nov, 2018

(5 years ago)

US6428810 ASTRAZENECA LP Pharmaceutical formulation comprising omeprazole
Nov, 2019

(4 years ago)

US6428810

(Pediatric)

ASTRAZENECA LP Pharmaceutical formulation comprising omeprazole
May, 2020

(4 years ago)

Drug Exclusivity Drug Exclusivity Expiration
RTO(RTO) Mar 28, 2017

Market Authorisation Date: 28 March, 2014

Treatment: Treatment of frequent heartburn by administering a gastric acid reducer; Method of treating frequent heartburn by administering an esomeprazole magnesium as claimed; Method of treating frequent heartb...

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of NEXIUM 24HR before it's drug patent expiration?
More Information on Dosage

NEXIUM 24HR family patents

Family Patents